Pharming Group (PHAR) News Today $14.00 -0.38 (-2.64%) Closing price 10/17/2025 03:57 PM EasternExtended Trading$14.29 +0.29 (+2.07%) As of 10/17/2025 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PHAR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Down 71.8% in SeptemberOctober 18 at 5:14 AM | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What HappenedOctober 15 at 1:15 PM | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Should You Buy?October 13, 2025 | marketbeat.comPharming Group (ENXTAM:PHARM): Assessing Valuation Following Major Cost-Cutting and Restructuring MoveOctober 10, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Earns "Sell (D+)" Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comPharming Group Announces Restructuring to Cut Costs and Boost GrowthOctober 8, 2025 | msn.comPharming Group (NASDAQ:PHAR) Shares Gap Down - What's Next?October 8, 2025 | marketbeat.comPharming announces 20% net reduction in non-commercial, non-medical headcountOctober 7, 2025 | msn.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Should You Buy?October 7, 2025 | marketbeat.comShort Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 64.2%October 6, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Stock Price Down 4.6% - What's Next?October 6, 2025 | marketbeat.comPharming Group provides update on previously announced G&A expense reduction planOctober 6, 2025 | markets.businessinsider.comPharming Group (NASDAQ:PHAR) Cut to "Hold" at Zacks ResearchOctober 2, 2025 | marketbeat.comPharming Group’s Leniolisib Receives FDA Priority Review for Pediatric APDS TreatmentOctober 1, 2025 | msn.comPharming Group (NASDAQ:PHAR) Stock Price Up 7% - Still a Buy?October 1, 2025 | marketbeat.comPharming shares jump 6% as FDA grants priority review for Joenja in childrenOctober 1, 2025 | investing.comPharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 yearsOctober 1, 2025 | tmcnet.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Time to Buy?September 30, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Time to Buy?September 29, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's WhySeptember 26, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next?September 23, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - What's Next?September 20, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Here's What HappenedSeptember 17, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Stock Price Down 4.4% - Here's WhySeptember 16, 2025 | marketbeat.comPharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Increase in Short InterestSeptember 14, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?September 13, 2025 | marketbeat.comPharming Group N.V.: Pharming Group promoted to the Euronext AMX indexSeptember 10, 2025 | finanznachrichten.dePharming Group promoted to the Euronext AMX® indexSeptember 10, 2025 | markets.businessinsider.comPharming Group N.V. (PHAR) Presents at H.C. Wainwright 27th Annual Global Investment Conference - SlideshowSeptember 8, 2025 | seekingalpha.comPharming Group (NASDAQ:PHAR) Shares Up 5% - Should You Buy?September 5, 2025 | marketbeat.comPharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Down 73.1% in AugustSeptember 5, 2025 | marketbeat.comPharming Group to present at the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 3, 2025 | finance.yahoo.comPharming Group names new finance headSeptember 2, 2025 | msn.comPharming Group appoints Kenneth Lynard as Chief Financial OfficerSeptember 2, 2025 | markets.businessinsider.comPharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Growth in Short InterestAugust 17, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Trading 1.2% Higher - Still a Buy?August 16, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?August 13, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Should You Sell?August 12, 2025 | marketbeat.comPharming Group NV (PHARMA.XD) - Yahoo FinanceAugust 10, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Hits New 1-Year High - Still a Buy?August 7, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Trading Up 7.9% - Should You Buy?August 5, 2025 | marketbeat.comPharming Group N.V. Reports Strong Q2 EarningsAugust 4, 2025 | theglobeandmail.comPharming Group to participate in August investor conferenceAugust 4, 2025 | uk.finance.yahoo.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume Following Better-Than-Expected EarningsAugust 2, 2025 | marketbeat.comPharming Group Second Quarter 2025 Earnings: EPS: US$0.007 (vs US$0.002 loss in 2Q 2024)August 2, 2025 | finance.yahoo.comPharming Group N.V. (PHAR) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | seekingalpha.comPharming Group N.V. 2025 Q2 - Results - Earnings Call PresentationAugust 1, 2025 | seekingalpha.comPharming Group (NASDAQ:PHAR) Shares Gap Up After Better-Than-Expected EarningsAugust 1, 2025 | marketbeat.comPharming Group reports second quarter and first half 2025 financial results and provides business updateJuly 31, 2025 | finance.yahoo.comHigh Growth Tech Stocks To Watch In Europe July 2025July 29, 2025 | finance.yahoo.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PHAR Media Mentions By Week PHAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼0.770.46▲Average Medical News Sentiment PHAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼43▲PHAR Articles Average Week Get the Latest News and Ratings for PHAR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Pharming Group and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SRRK News Today VKTX News Today MIRM News Today LNTH News Today ADMA News Today ACAD News Today ZLAB News Today QURE News Today CGON News Today AAPG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAR) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThis dark force is about to change everythingSomething unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredElon’s Optimus to mint new “Musk Millionaires” as soon as Oct 23???Elon Musk may be set to create more "Musk Millionaires" as soon as October 23rd… Because on that day, he's exp...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group N.V. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
